Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia, UCSF Collaborate on AI-Based Pathology for Cancer Diagnosis

By Author Proscia | March 2, 2020

Proscia said on Monday that it is partnering with the University of California, San Francisco with the aim of introducing artificial intelligence into the practice of pathology.

Beginning with prostate cancer, the collaboration will aim to validate the clinical efficacy of computational pathology applications for several high-impact pathology subspecialties, Proscia said.

Our website uses cookies. By using this site, you agree to its use of cookies.